Guided Therapeutics EV / EBITDA
Was ist das EV / EBITDA von Guided Therapeutics?
EV / EBITDA von Guided Therapeutics, Inc. ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Guided Therapeutics
Was macht Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Unternehmen mit ev / ebitda ähnlich Guided Therapeutics
- Exro Technologies Inc hat EV / EBITDA von N/A
- Pacific Imperial Mines hat EV / EBITDA von N/A
- Kalina Power hat EV / EBITDA von N/A
- TransAtlantic Petroleum Ltd hat EV / EBITDA von N/A
- CBD Global Sciences hat EV / EBITDA von N/A
- Paradigm Biopharmaceuticals hat EV / EBITDA von N/A
- Guided Therapeutics hat EV / EBITDA von N/A
- KRM22 Plc hat EV / EBITDA von N/A
- CMC Metals hat EV / EBITDA von N/A
- Lamaska Capital hat EV / EBITDA von N/A
- Riverside Resources hat EV / EBITDA von N/A
- Canarc Resource hat EV / EBITDA von N/A
- RTG Mining hat EV / EBITDA von N/A